I’d be interested if anyone has access/subscription to resources like Ibisworld to see if there’s stats or figures on sleep apnoea diagnosis market to give us a rough guide on what SleepCheck could be worth to RAP in US.
Even if we worked off a small percentage of the market, it’s got to have raised the value and prospects of the company in the IER.
- Forums
- ASX - By Stock
- RAP
- Ann: ResApp receives FDA 510(k) clearance for SleepCheckRx
Ann: ResApp receives FDA 510(k) clearance for SleepCheckRx, page-104
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online